Patrick D. Spangler, Director at OptimizeRx Corp (OPRX), bought 95 shares at $9.95 ($945) on 2018-06-27, disclosed to the SEC on 2018-06-28.
Open-market purchase of $945 OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| EVVV | SELL | 2008-11-18 | $12K | — | Filing → |
| EVVV | SELL | 2007-11-19 | $25K | — | Filing → |